Picture of Neovacs SA logo

ALNEV Neovacs SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Neovacs Announces EUR 0.5 Mln Fundraising Through OCEANE-BSA

April 18 (Reuters) - Neovacs SA  ALNEV.PA :
    * FUNDRAISING OF 0.5 MEUR
    * SET UP A FINANCING IN THE FORM OF OCEANE-BSA WITH THE
EUROPEAN
HIGH GROWTH OPPORTUNITIES SECURITIZATION FUND, WHICH, AFTER
RECEIVING THE SHARES RESULTING FROM THE CONVERSION OR EXERCISE
OF THESE INSTRUMENTS, WILL NOT REMAIN A SHAREHOLDER OF THE
COMPANY
    * THE SHARES RESULTING FROM THE CONVERSION OR EXERCISE OF
THE
ABOVE-MENTIONED SECURITIES WILL, IN GENERAL, BE SOLD IN THE
MARKET AT VERY SHORT NOTICE, WHICH MAY CREATE STRONG DOWNWARD
PRESSURE ON THE SHARE PRICE
    * THE NET PROCEEDS OF THIS OPERATION (€480,000) WILL BE USED
TO
FINANCE THE KINOÏDE® ALLERGY RESEARCH PROGRAM 2  (50%) AND TO
STRENGTHEN THE COMPANY'S CAPACITY TO INVEST IN PROMISING
PROJECTS, BOTH IN THE DEVELOPMENT OF DRUG CANDIDATES (BIOTECH)
AND MEDICAL DEVICES (MEDTECH)

Source text for Eikon:  ID:nACT79400 
Further company coverage:  ALNEV.PA 

 (Gdansk Newsroom)
 ((Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Neovacs SA

See all news